|
Immunotherapy with CAR-T cells against stromal antigens for the treatment of PDAC
|
AC23_1/00005
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects of partnership international
|
18-12-2023
|
235.950,00€
|
-
|
|
IDENTIFICATION OF TRANSCRIPTIONAL MECHANISMS OF PROGRESSION AND RESISTANCE TO TREATMENT IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC
PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES
|
PI23/00516
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
228.750,00€
|
ERDF funds
|
|
Characterization of Chronic Spontaneous Urticaria Based on Response to Antihistamines: Approach to Intracellular Signaling Molecules.
|
PI23/01280
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
215.000,00€
|
ERDF funds
|
|
Conditional co-stimulation through 4-1BB exploiting Crosspriming in cancer CONDICOS
|
CPP2022-009762
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI PARTNERSHIP PUBLIC PRIVATE
|
18-12-2023
|
184.763,20€
|
MRR Funds
|
|
essay Phase I clinical trial of a new antifibrinolytic agent, compound CM-352, with an efficient synthesis route, aimed at the control of disabling and lethal bleeding.
|
CPP2022-009643
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI PARTNERSHIP PUBLIC PRIVATE
|
18-12-2023
|
1.161.981,80€
|
MRR Funds
|
|
DSTYK inhibition as the basis for a novel targeted therapy to break resistance to standard treatments in lung cancer
|
PI23/00223
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
FIMA 2023 AES research Projects
|
18-12-2023
|
177.500,00€
|
ERDF funds
|
|
RYC2022-036689-I K.VALENCIA
|
RYC2022-036689-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
RYC2022-036819-I M. MONTES
|
RYC2022-036819-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
RYC2022-036929-I RAFAEL VALDES
|
RYC2022-036929-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
assessment of neutron dose in a proton therapy facility: implications for the pediatric patient and worker.
|
PI23/00157
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
14-12-2023
|
127.500,00€
|
ERDF funds
|
|
|
|
|
|
|
|
|
